Publication:
From probands to relatives

dc.contributor.coauthorShah, Lisa L.
dc.contributor.coauthorYazici, Hulya
dc.contributor.coauthorDaack-Hirsch, Sandra
dc.contributor.departmentN/A
dc.contributor.kuauthorSeven, Memnun
dc.contributor.kuprofileFaculty Member
dc.contributor.schoolcollegeinstituteSchool of Nursing
dc.contributor.yokid32470
dc.date.accessioned2024-11-10T00:07:06Z
dc.date.issued2022
dc.description.abstractBackground The genetic risk communication from proband to relatives varies from family to family, and patients often need support with the communication of genetic test results and making decisions to manage hereditary cancer risks. Objective The aim of this study was to characterize the communication of BRCA1 or BRCA2 (BRCA1/2) genetic risk from proband to first-degree relatives (FDRs) using a social network framework. Methods We characterized network and nonnetwork factors to explore their association with which FDRs were told about the genetic risk and whether or not relatives underwent genetic testing. Ninety-two female probands with hereditary breast and ovarian cancer who have confirmed BRCA1/2 mutations participated in the study. Communication of hereditary breast and ovarian cancer risk was assessed between 92 probands and their 417 FDRs. Results of 92 probands, 94.5% (n = 87) communicated their genetic test result to at least one of their FDRs. of FDRs older than 18 years, 19.9% (n = 72) have genetic testing. Emotional closeness, educational level of the proband, and relative's age were significantly associated with communicating test results with FDRs. Conclusion Communication of genetic risk with the FDRs after having a BRCA1/2 gene-mutation-positive test result was high in this group of cancer patients. However, the rate of genetic testing among FDRs was low. Implications for Practice Probands' educational level and age of relatives for cascade genetic screening should be considered during counseling. Interventions to support women with BRCA1/2 mutations during the communication process and their family members' engagement in testing and risk-reducing strategies are needed.
dc.description.indexedbyWoS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue1
dc.description.openaccessNO
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.sponsorshipThis study was funded by European Oncology Nursing Society Research Grant 2015. L.L.S. is supported by an NIH/NINR T32 postdoctoral fellowship (T32NR0097590).
dc.description.volume45
dc.identifier.doi10.1097/NCC.0000000000000876
dc.identifier.eissn1538-9804
dc.identifier.issn0162-220X
dc.identifier.quartileQ1
dc.identifier.scopus2-s2.0-85121042569
dc.identifier.urihttp://dx.doi.org/10.1097/NCC.0000000000000876
dc.identifier.urihttps://hdl.handle.net/20.500.14288/16727
dc.identifier.wos725809900020
dc.keywordsCommunication
dc.keywordsFamily network
dc.keywordsGenetic risk
dc.keywordsHereditary cancer
dc.languageEnglish
dc.publisherLippincott Williams and Wilkins (LWW)
dc.sourceCancer Nursing
dc.subjectOncology
dc.subjectNursing
dc.titleFrom probands to relatives
dc.title.alternativeFrom probands to relatives: communication of genetic risk for hereditary breast-ovarian cancer and its influence on subsequent testing
dc.typeJournal Article
dspace.entity.typePublication
local.contributor.authorid0000-0002-6981-8877
local.contributor.kuauthorSeven, Memnun

Files